Matthew D. Tallant
Research Triangle Park Foundation(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, HIV Research and Treatment, Biochemical and Molecular Research, Chemical synthesis and alkaloids
Most-Cited Works
- → Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents(2013)67 cited
- → Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease(2010)46 cited
- → Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical Compound(2014)43 cited
- → Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties(2011)42 cited
- → Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants(2012)40 cited
- → Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease(2010)30 cited
- → Exo-Selective Diels−Alder Reactions of Vinylazepines. Origin of Divergent Stereoselectivity in Diels−Alder Reactions of Vinylazepines, Vinylpiperideines, and Vinylcycloalkenes(2003)22 cited
- → Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1(2011)10 cited
- → Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups(2012)6 cited
- → Metal Ion Complexation and Extraction Behavior of Some Acyclic Analogs of tert-Butyl-calix[4]arene Hydroxamate Extractants(2000)1 cited